Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Explore which index funds have low turnover and how this characteristic can reduce tax drag, improving after-tax results for long-term investing.
27,549 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Micron reports a record quarterly beat on AI memory demand, sending MU stock higher and underscoring a broader shift ...
A major settlement shines a light on insulin pen refill practices in government health programs. This article explain...
A prominent SaaS executive warns that AI could erode long-standing moats, while industry data show enduring protectio...
Investors are focusing on the links between battlefield tech and defense earnings as analysts highlight the firearms ...
XRP has fallen more than ripple's in the latest market cycle, even as Ripple signs big-bank deals and the XRP Ledger ...
Lockheed Martin has surged about 26% in 2026. Before you chase the rally, learn how to assess whether the stock still...
Figma’s latest revenue surge has caught the eye of investors staring at a beaten-down stock. This article breaks down...
Volatility is shaping a smarter approach to investing. Discover three growth stocks worth $5,000 and how to build a f...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
Meta Platforms is nudging into cloud computing, aiming to monetize idle compute and AI-ready infrastructure. This art...
A Supreme Court ruling curbs the president’s tariff powers under IEEPA, easing uncertainty for manufacturers. A CFO w...